RCSV Member featured in Xinhua Net, sharing on repeated low-level red-light therapy for controlling myopia progression

Prof. He Mingguang, Member of the Research Centre for SHARP Vision (RCSV) and Chair Professor of Experimental Ophthalmology in the School of Optometry, in an interview with Xinhua Net, shared his insights on the use of repeated low-level red-light therapy for controlling myopia progression in children and young persons.

“The emergence of red light has enabled the light therapy as a new type of treatment for myopia control, in addition to the two conventional methods of drug treatment and optical control,” Prof. He said.

He further explained the principles underlying the therapy: the light feeder uses red light with a wavelength of 650 nanometres, to stimulate and improve the blood circulation on the ocular fundus using safe power and effective duration, thereby thickening the choroid, improving oxygen supply to the scleral, and thus, inhibiting the increase of axial length in eyes and controlling the progression of myopia.

Online coverage:
Xinhua Net - https://polyu.me/44M6OXb (Chinese only)
ifeng.com - https://polyu.me/3O9BYAR (Chinese only)
Global News - https://polyu.me/476lZvT (Chinese only)
People.cn - https://polyu.me/3QcTo25 (Chinese only)